NR 567 Week 3 Clinical Decision-Making Discussion.

$15.00

Description

  1. Explain why an Ace Inhibitor is recommended for a patient who has just experienced an ST-Elevation Myocardial Infarction (STEMI).
  2. Which pharmaceutical agent (include dose, route, frequency) would you prescribe for this patient? Explain your rationale.
  3. Determine whether the Ace Inhibitor will protect the patient from having a cardiac arrhythmia post STEMI? Explain your rationale.

Response to Professor

In what circumstance or circumstances would ACEIs not be used in this setting? Are there alternatives? What literature exists around these alternatives?

Additional information

Insituition

Chamberlain

Contributor

Martha Nielsen

Language

English

Document Type

Microsoft Word